These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 24767215)
1. New oral anticoagulants and oculoplastic surgery. Ing E; Douketis J Can J Ophthalmol; 2014 Apr; 49(2):123-7. PubMed ID: 24767215 [TBL] [Abstract][Full Text] [Related]
2. [New direct oral anticoagulants and venous thromboprophylaxis]. Degirmenci SE; Steib A Rev Prat; 2013 Sep; 63(7):976-9. PubMed ID: 24167901 [TBL] [Abstract][Full Text] [Related]
3. Are new oral anticoagulant dosing recommendations optimal for all patients? Powell JR JAMA; 2015 Mar; 313(10):1013-4. PubMed ID: 25756434 [No Abstract] [Full Text] [Related]
4. Perioperative management of patients on new oral anticoagulants. Lai A; Davidson N; Galloway SW; Thachil J Br J Surg; 2014 Jun; 101(7):742-9. PubMed ID: 24777590 [TBL] [Abstract][Full Text] [Related]
5. Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants. Schmitz EM; Boonen K; van den Heuvel DJ; van Dongen JL; Schellings MW; Emmen JM; van der Graaf F; Brunsveld L; van de Kerkhof D J Thromb Haemost; 2014 Oct; 12(10):1636-46. PubMed ID: 25142183 [TBL] [Abstract][Full Text] [Related]
6. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis. Harenberg J; Marx S; Diener HC; Lip GY; Marder VJ; Wehling M; Weiss C Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398 [TBL] [Abstract][Full Text] [Related]
7. [Evidence of novel oral anticoagulants (NOAC)]. Kitazono T Rinsho Shinkeigaku; 2013; 53(11):992-3. PubMed ID: 24291856 [TBL] [Abstract][Full Text] [Related]
8. [Rivaroxaban, dabigatran and apixaban: new anticoagulants in operative urology]. John A; Michel MS Urologe A; 2014 Jun; 53(6):893-902; quiz 903. PubMed ID: 24845012 [TBL] [Abstract][Full Text] [Related]
9. [Stroke prevention in atrial fibrillation : old and new anticoagulants]. Darius H; Sommer S Herz; 2013 May; 38(3):231-8. PubMed ID: 23632424 [TBL] [Abstract][Full Text] [Related]
10. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era. Contractor T; Levin V; Martinez MW; Marchlinski FE Postgrad Med; 2013 Jan; 125(1):34-44. PubMed ID: 23391669 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of new oral anticoagulants compared with warfarin in preventing stroke and other cardiovascular events in patients with atrial fibrillation. Coyle D; Coyle K; Cameron C; Lee K; Kelly S; Steiner S; Wells GA Value Health; 2013 Jun; 16(4):498-506. PubMed ID: 23796283 [TBL] [Abstract][Full Text] [Related]
12. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation. Lip GY; Larsen TB; Skjøth F; Rasmussen LH J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324 [TBL] [Abstract][Full Text] [Related]
13. Is there a role for novel oral anticoagulants in patients with an acute coronary syndrome? A review of the clinical trials. Liew A; Darvish-Kazem S; Douketis JD Pol Arch Med Wewn; 2013; 123(11):617-22. PubMed ID: 24466582 [TBL] [Abstract][Full Text] [Related]
14. [Stroke prevention after stroke in patients with atrial fibrillation: a case-based review]. Kovács T Orv Hetil; 2014 Oct; 155(42):1655-60. PubMed ID: 25305723 [TBL] [Abstract][Full Text] [Related]
15. Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study. Banerjee A; Lane DA; Torp-Pedersen C; Lip GY Thromb Haemost; 2012 Mar; 107(3):584-9. PubMed ID: 22186961 [TBL] [Abstract][Full Text] [Related]
16. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future]. Dumont B; Faille D; Ajzenberg N Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670 [TBL] [Abstract][Full Text] [Related]
17. What's the "go to" anticoagulant for stroke prevention in atrial fibrillation? Goldhaber SZ Thromb Haemost; 2012 Mar; 107(3):397-8. PubMed ID: 22318737 [No Abstract] [Full Text] [Related]
18. New oral anticoagulants for non-valvular atrial fibrillation--safety issues. Barry M Ir Med J; 2013 Mar; 106(3):69. PubMed ID: 23951972 [No Abstract] [Full Text] [Related]
19. Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants. Cuker A; Siegal DM; Crowther MA; Garcia DA J Am Coll Cardiol; 2014 Sep; 64(11):1128-39. PubMed ID: 25212648 [TBL] [Abstract][Full Text] [Related]
20. The new oral anticoagulants: a challenge for hospital formularies. Merli GJ Hosp Pract (1995); 2012 Aug; 40(3):126-8. PubMed ID: 23086101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]